Connect with us

Health

Novel vectors reduce the risks associated with ocular gene therapies – News-Medical.net

Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development.

Published

on

Article feature image

Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development. Novel gene vectors now achieve widespread gene delivery and reduce the risks associated with these approaches.
The incidence of genetic mutations that result in rapid deterioration of the ability to see is larger than is generally supposed. For example, on the order of five million people around the world suffer from congenital retinal dystrophies, which often lead…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Study could offer a new way to treat Type 1 and Type 2 diabetes – News-Medical.Net
Article feature image
Scientists test the effect of natural product isolated from sea sponge on cancer cells – News-Medical.net